Cell Transformation Group:Resources/Cell Lines/Human Cell lines
From OpenWetWare
Jump to navigationJump to search
<owwmenu> image="A549_web.jpg" font="arial, helvetica, sans-serif" bold="1" color="blue" bgcolor="Cornsilk" hovercolor="lightcyan"
bghovercolor="rosybrown" topFontSize="15" fontSize="10" pagewidth="800" lab="Cell Transformation Group">
Home=#, Home=http://openwetware.org/wiki/Cell_Transformation_Group
Members
Research=#,Ongoing=Ongoing_Research
Protocols=#,Cell_Culture=Protocols/Cell Culture,Protein=Protocols/Protein,RNA_and_DNA=Protocols/RNA and DNA
Resources=#,Cell Lines=Resources/Cell Lines,Virus_Stocks=Resources/Virus Stocks,Glycerols=Resources/Glycerols,Antibodies=Resources/Antibodies
Links=#, Sponsors=Links/Sponsors
</owwmenu>
White Rack (Rack 1) | Blue Rack (Rack 2) | Red Rack (Rack 3)
Non-Human Cell Lines | GM-Non-Human Cell Lines | Human Cell Lines | GM-Human Cell Lines
Human Cell Lines
For Active answer Y (yes), N (no), D (destroyed).
| Cell Line | Passage | Date | Box | Vials | Species | Notes | Import Date | Approval # | Active |
|---|---|---|---|---|---|---|---|---|---|
| 143b | 3 | 14/8/96 | 3 | 1 | Human | Bone osteosarcoma | Prior to 1/1/98 | N | |
| 143b | 11 | 23/9/98 | 1 | 1 | Human | Bone osteosarcoma | Prior to 1/1/98 | N | |
| 143b | 11 | 30/7/01 | 1 | 1 | Human | Bone osteosarcoma | Prior to 1/1/98 | N | |
| 143b | 13 | 27/4/05 | 5 | 3 | Human | Bone osteosarcoma | Prior to 1/1/98 | N | |
| 293 | 5/2/04 | 2 | 1 | Human | Prior to 1/1/98 | Y | |||
| 293 | 5/6/04 | 2 | 2 | Human | Prior to 1/1/98 | Y | |||
| 293 | 6/6/04 | 2 | 2 | Human | Prior to 1/1/98 | Y | |||
| 293 | 9/9/04 | 2 | 6 | Human | Prior to 1/1/98 | Y | |||
| 293 | 10/12/04 | 2 | 1 | Human | Prior to 1/1/98 | Y | |||
| 769P | 29 | 3/4/05 | 8 | 3 | Human | Primary renal adenocarcinoma | N | ||
| 786O | 110 | 2/4/05 | 8 | 3 | Human | Primary renal adenocarcinoma | N | ||
| IIICF/c | Human | From Roger Reddell/Jeremy Henson | 2/5/07 | B2007/115543 | Y | ||||
| IIICF/c | 16/10/02 | 18 | 3 | Human | Li-Fraumeni patient lung cell line | Prior to 1/1/98 | Y | ||
| IIICF/c | 17/1/03 | 7 | 1 | Human | Li-Fraumeni patient lung cell line | Prior to 1/1/98 | Y | ||
| IIICF/c | 2/2/04 | 1 | 4 | Human | Li-Fraumeni patient lung cell line | Prior to 1/1/98 | Y | ||
| IIICF/c | 7/2/05 | 7 | 7 | Human | Li-Fraumeni patient lung cell line | Prior to 1/1/98 | Y | ||
| IIICF/c | +p1 | 27/1/03 | 18 | 9 | Human | Li-Fraumeni patient lung cell line | Prior to 1/1/98 | Y | |
| IIICF/c | +p3 | 26/10/04 | 18 | 4 | Human | Li-Fraumeni patient lung cell line | Prior to 1/1/98 | Y | |
| A172 | 1 | 14/5/04 | 15 | 1 | Human | CRL1620, Glioblastoma | Y | ||
| A172 | 6 | 06 | 15 | 2 | Human | CRL1620, Glioblastoma | Y | ||
| A204 HTB82 | 16 | 16/7/04 | 4 | 2 | Human | Prior to 1/1/98 | N | ||
| A549 | 8 | 7/5/98 | 4 | 1 | Human | Mycoplasma -ve, lung carcinoma | Prior to 1/1/98 | Y | |
| A549 | 14 +12pd | 16/7/04 | 18 | 1 | Human | Lung carcinoma | Prior to 1/1/98 | Y | |
| A549 | 16 | 16/7/04 | 4 | 1 | Human | Lung carcinoma | Prior to 1/1/98 | Y | |
| A549 | 17/8/01 | 9 | 2 | Human | Lung carcinoma | Prior to 1/1/98 | Y | ||
| A549 | 31/10/05 | 9 | 2 | Human | Lung carcinoma | Prior to 1/1/98 | Y | ||
| A549 | 16/12/05 | 9 | 4 | Human | Lung carcinoma | Prior to 1/1/98 | Y | ||
| A673 | 21/5/97 | 4 | 1 | Human | CRL1598 | Prior to 1/1/98 | N | ||
| A673 | 13/2/01 | 2 | 1 | Human | Prior to 1/1/98 | N | |||
| A673 | 12/4/05 | 2 | 2 | Human | Prior to 1/1/98 | N | |||
| A2182 | 11 | 2/2/01 | 2 | 1 | Human | Prior to 1/1/98 | N | ||
| ACHN | 4 | 14/1/04 | 8 | 2 | Human | N | |||
| AT1BR44neo | Human | Alt cell line from Roger Reddel/Jeremy Henson | 2/5/07 | B2007/115543 | N | ||||
| B6RD | 43 | 14/5/97 | 4 | 1 | Human | ATCC CCL B6RD, Rhabdomyosarcoma | Prior to 1/1/98 | N | |
| B6RD | 46 | 4/12/96 | 1 | 1 | Human | ATCC CCL B6RD, Rhabdomyosarcoma | Prior to 1/1/98 | N | |
| Bre16 | 3 | 26/11/03 | 18 | 1 | Human | pre T150 | N | ||
| Bre16 | post p10 | 21/12/03 | 18 | 1 | Human | N | |||
| Bre16 | p16 +pd3 | 6/9/03 | 18 | 1 | Human | N | |||
| Bre24 | pre p2 | 14/3/04 | red1 | 1 | Human | +L50 | N | ||
| Bre24 | post p8 | 21/4/04 | red1 | 1 | Human | T + 5110 | N | ||
| Bre24 | post p11 | 21/4/04 | red1 | 1 | Human | T + 5110 | N | ||
| Bre28 | 4/11/04 | red1 | 2 | Human | Br tissue 2Gy | N | |||
| Bre38 | 14 | 14/3905 | 18 | 1 | Human | N | |||
| Bre80 | 11 | 15/1/98 | 10 | 2 | Human | 15/4/02 | N | ||
| Bre80 | 12 | 27/5/02 | 10 | 1 | Human | 15/4/02 | N | ||
| Bre80 | post p16 | 21/4/04 | 18 | 1 | Human | 15/4/02 | N | ||
| Bre80 | post p16 +2pd | 16/7/04 | 18 | 3 | Human | 15/4/02 | N | ||
| Bre80 | p16 +pd3 | 6/9/04 | 18 | 1 | Human | 15/4/02 | N | ||
| Bre80 | 17 | 28/11/04 | red1 | 1 | Human | LTL50 | 15/4/02 | N | |
| Bre80 | pp25 | 6/11/05 | 10 | 2 | Human | 15/4/02 | MAF00100728848 | N | |
| Bre80 | pd48 | 6/9/04 | 10 | 2 | Human | Anna's | 15/4/02 | N | |
| Bre80 | 51 | 17/12/04 | red1 | 1 | Human | Basal post TL50 | 15/4/02 | N | |
| BT20 | 9 | 6/11/01 | 10 | 1 | Human | N | |||
| BT549 | 2 | 15/5/034 | 10 | 1 | Human | RPMI, 10% CO2 | N | ||
| C33A | 116 | 10/9/04 | 1 | 2 | Human | Mycoplasma -ve | Prior to 1/1/98 | N | |
| C33A | 118 | 10/9/04 | 1 | 3 | Human | Mycoplasma -ve | Prior to 1/1/98 | N | |
| C33A | 118 | 11/9/04 | 1 | 2 | Human | Mycoplasma -ve | Prior to 1/1/98 | N | |
| C33A | 118 | 5/10/05 | 7 | 6 | Human | Prior to 1/1/98 | N | ||
| CCRF CEMf2 | 3 | 15/3/03 | 10 | 1 | Human | RPMI 10%CO2 | N | ||
| DBTRG 05MG | 11 | 2 | Human | N | |||||
| Fre24 | 6 | 4/5/04 | red1 | 1 | LTH | N | |||
| Fre28 | 26 | 19/12/04 | red1 | 2 | TL50 | N | |||
| G-292 | Human | Alt cell line from Roger Reddel/Jeremy Henson | 2/5/07 | B2007/115543 | N | ||||
| GM0637 | 11/5/07 | 5 | 2 | Human | Alt cell line from Roger Reddel/Jeremy Henson | 2/5/07 | B2007/115543 | N | |
| GM639DM | 7 | 23/3/00 | 4 | 1 | Human | Mycoplasma -ve | N | ||
| GM639DM | 11 | 1/11/01 | 7 | 3 | Human | N | |||
| GM639DM | 12 | 8/12/02 | 17 | 12 | Human | N | |||
| GM847DM | 11/5/07 | 5 | 2 | Human | Alt cell line from Roger Reddel/Jeremy Henson | 2/5/07 | B2007/115543 | N | |
| GM847DM | 55 | 19/11/01 | 4 | 5 | Human | Mycoplasma +ve | N | ||
| GM847DM | 56 | 9/12/02 | 17 | 3 | Human | N | |||
| GM2096/SV9 | 6 | 23/3/00 | 4 | 1 | Human | Mycoplasma -ve | N | ||
| GM2096/SV9 | 11 | 1/11/01 | 7 | 3 | Human | N | |||
| GM2096/SV9 | 12 | 8/12/02 | 17 | 15 | Human | N | |||
| H4 | 261 | 20/5/05 | 16 | 2 | Human | N | |||
| H24-H1299 | 6 | 5/7/01 | 7 | 1 | Human | 27/10/98 | MAF1998002334 | N | |
| H24-H1299 | 9/2/01 | 7 | 1 | Human | 27/10/98 | MAF1998002334 | N | ||
| HCT116 P21-/- | 10 | 16/12/02 | RED2 | 1 | Human | Colorectal carcinoma | 9/12/02 | Y | |
| HCT116 P21-/- | 13 | 13/12/02 | RED2 | 1 | Human | Y | |||
| HCT116 P21-/- | 15 | RED2 | 3 | Human | Y | ||||
| HCT116 P21-/- | 16 | RED2 | 4 | Human | Y | ||||
| HCT116 P21+/+ | 11 | 16/12/02 | RED2 | 4 | Human | 9/12/02 | Y | ||
| HCT116 P21+/+ | 14 | 24/11/03 | 2 | 7 | Human | 9/12/02 | Y | ||
| HCT116 P21+/+ | 14 | 23/6/06 | RED2 | 3 | Human | 9/12/02 | Y | ||
| HCT116 P26+/+ | 14 | 24/11/03 | 2 | 1 | Human | 9/12/02 | Y | ||
| HCT116 P53-/- | 11 | RED2 | 3 | Human | Y | ||||
| HCT116 P53-/- | 12 | RED2 | 3 | Human | Y | ||||
| HCT116 P53-/- | 15 | 26/2/04 | 15 | 1 | Human | Y | |||
| HCT116 P53+/+ | 11 | 16/12/02 | RED2 | 4 | Human | 9/12/02 | Y | ||
| HCT116 P53+/+ | 13? | 1/8/06 | RED2 | 2 | Human | 9/12/02 | Y | ||
| HCT116 P53+/+ | 15 +2PD | 18/1/05 | 15 | 2 | Human | 9/12/02 | Y | ||
| HeLa | 28/6/00 | 4 | 1 | Human | Prior to 1/1/98 | Y | |||
| HeLa | 21/11/00 | 7 | 1 | Human | Prior to 1/1/98 | Y | |||
| HeLa | 5/10/05 | 7 | 2 | Human | Prior to 1/1/98 | Y | |||
| Hep3B | 11/6/97 | 4 | 2 | Human | HepB +ve, ATCC HB8044 | Prior to 1/1/98 | N | ||
| Hep3B | 17/10/97 | 4 | 2 | Human | HepB +ve, ATCC HB8044 | Prior to 1/1/98 | N | ||
| Hep3B | 27/1/98 | 1 | 6 | Human | HepB +ve | Prior to 1/1/98 | N | ||
| HepG2 | 4/11/98 | 6 | 1 | Human | Prior to 1/1/98 | N | |||
| HepG2 | 7/2/01 | 6 | 1 | Human | Prior to 1/1/98 | N | |||
| HepG2 | 16/7/01 | 6 | 3 | Human | Prior to 1/1/98 | N | |||
| HepG2 | 26/4/05 | 6 | 2 | Human | Prior to 1/1/98 | N | |||
| HF | 1 | 30/4/04 | 1 | 1 | Human | Prior to 1/1/98 | N | ||
| HF | 1 | 17/5/04 | 1 | 2 | Human | Prior to 1/1/98 | N | ||
| HF | 3 | 13/8/04 | 18 | 3 | Human | Prior to 1/1/98 | N | ||
| HF | 4 | 5/11/02 | 7 | 1 | Human | Prior to 1/1/98 | N | ||
| HF | 4 | 6/8/04 | 2 | 2 | Human | Prior to 1/1/98 | N | ||
| HF | 7 | 30/1/03 | 7 | 2 | Human | Prior to 1/1/98 | N | ||
| HF | 7 | 8/2/03 | 18 | 6 | Human | Prior to 1/1/98 | N | ||
| HF | 11 | 2/4/03 | 8 | 4 | Human | Prior to 1/1/98 | N | ||
| HF | 12 | 19/10/04 | 8 | 4 | Human | Prior to 1/1/98 | N | ||
| HF | 17 | 29/11/04 | 15 | 2 | Human | Anna's ?-p53 p16 | Prior to 1/1/98 | N | |
| HF | 19 | 29/11/04 | 15 | 3 | Human | Anna's from DDLe | Prior to 1/1/98 | N | |
| HF | 26 | 29/4/02 | 8 | 1 | Human | Prior to 1/1/98 | N | ||
| HF | pd2 | 18 | 3 | Human | ex tissue | Prior to 1/1/98 | N | ||
| HF | 14/5/01 | 8 | 1 | Human | T24 | Prior to 1/1/98 | N | ||
| HF D4 | 5 | 2/3/01 | 8 | 1 | Human | Prior to 1/1/98 | N | ||
| HFF5/hTERT-1 | 11 pd32IN | 7/4/04 | 18 | 1 | Human | New +p16 cells | N | ||
| HFF5/hTERT-1 | pd71 | 18 | 7 | Human | Ex Roger Reddell p16+ve | N | |||
| HFF5/hTERT-1 | pd111 | 18 | 5 | Human | Ex Roger Reddell p16-ve | N | |||
| HFF D2 | 10 | 27/10/98 | 7 | 3 | Human | Mycoplasma -ve | Prior to 1/1/98 | N | |
| HFF D5 | 9 | 1/2/98 | 7 | 5 | Human | Prior to 1/1/98 | N | ||
| HL60 | 23/4/05 | 15 | 3 | Human | Suspension cell line | N | |||
| HL60 | 12/7/05 | 15 | 1 | Human | N | ||||
| HL60 | 06 | 15 | 2 | Human | N | ||||
| HOP62 | 5 | 31/1/04 | 15 | 3 | Human | N | |||
| HOP62 | 6 | 4/2/04 | 15 | 2 | Human | N | |||
| HoSE6-2 | 40 | 300909 | -70 | 1 | Human | 240909 | NOC99008 | N | |
| HoSE11-12 | 40 | 300909 | -70 | 2 | Human | 240909 | NOC99008 | N | |
| HoSE17-1 | 40 | 300909 | -70 | 2 | Human | 240909 | NOC99008 | N | |
| HS683 | 06 | 15 | 4 | Human | N | ||||
| HT29 | 6 | 3/2/98 | 5 | 1 | Human | Prior to 1/1/98 | N | ||
| HT29 | 31/1/01 | 5 | 2 | Human | Prior to 1/1/98 | N | |||
| HT29 | 19/11/01 | 5 | 4 | Human | Prior to 1/1/98 | N | |||
| HT1080 | 21 | 8/8/96 | 2 | 1 | Human | Mycoplasma -ve | 1/3/98 | MAF1998002334 | N |
| HT1080 | 23 | 30/1/98 | 5 | 1 | Human | 1/3/98 | MAF1998002334 | N | |
| HT1080 | 30/1/01 | 5 | 3 | Human | 1/3/98 | MAF1998002334 | N | ||
| HT1080 | 23/4/05 | 5 | 3 | Human | 1/3/98 | MAF1998002334 | N | ||
| HT1080 6CTG | 16/2/99 | 5 | 6 | Human | 1/4/98 | MAF1998002334 | N | ||
| HT1080 6TGR | 10 | 21/4/98 | 5 | 1 | Human | Mycoplasma -ve | 1/4/98 | MAF1998002334 | N |
| HT1080 6TGR | 10 | 21/4/98 | 5 | 2 | Human | Mycoplasma -ve | 1/4/98 | MAF1998002334 | N |
| HT1080 MDM2 | 4/6/98 | 5 | 4 | Human | Mycoplasma -ve | 1/4/98 | MAF1998002334 | N | |
| HT1080 MDM2 | 4/6/98 | 5 | 2 | Human | 1/4/98 | MAF1998002334 | N | ||
| HT1080 MDM2 | 1/8/05 | 5 | 3 | Human | Mycoplasma -ve | 1/4/98 | MAF1998002334 | N | |
| HUVEC | p3+4 | 24/4/02 | 15 | 3 | Human | 5/4/02 SPG | N | ||
| HUVEC | 24/4/02 | 15 | 1 | Human | 5/4/02 SPG | N | |||
| IN324 | P13PDX4.5 | 21/1/04 | 1 | 1 | Human | Glioma study | N | ||
| IN699 | 11 | 12/10/03 | 16 | 1 | Human | Glioma study | N | ||
| IN699 | 12 | 16/10/03 | 16 | 2 | Human | Glioma study | N | ||
| IN699 | 13 | 03 | 16 | 1 | Human | Glioma study | N | ||
| IN699 | 19 | 06 | 6 | 2 | Human | Glioma study | N | ||
| IN699 | 16 pdx3 | 13/3/03 | 17 | 3 | Human | + Gent, Glioma study | N | ||
| IN1163 | 8 | 04 | 16 | 1 | Human | Glioma study | N | ||
| IN1180 | 23 | 05 | 16 | 1 | Human | Glioma study | N | ||
| IN1495 | 14 | 17/8/04 | 17 | 2 | Human | Not found IN2044 + IN1885 in places, Glioma study | N | ||
| IN1523 | 13 pdx5 | 21/11/03 | 17 | 2 | Human | Gentam, Glioma study | N | ||
| IN1523 | 15 pdx8 | 8/12/03 | 17 | 3 | Human | Pen Strep, Glioma study | N | ||
| IN1869 | 7 | 12/10/03 | 16 | 1 | Human | Glioma study | N | ||
| IN1869 | 17 | 04 | 16 | 1 | Human | Glioma study | N | ||
| IN1869 | 06 | 16 | 2 | Human | Glioma study | N | |||
| IN1869 | 12 pdx3 | 21/11/03 | 17 | 1 | Human | + Gentam, Glioma study | N | ||
| IN2017 | 28/4/05 | 16 | 2 | Human | Glioma study | N | |||
| IN2044 | 18 | 29/11/04 | 16 | 1 | Human | Glioma study | N | ||
| IN11631 | 13/9/04 | 17 | 2 | Human | Glioma study | N | |||
| J82 | 62 | 21/10/97 | 4 | 3 | Human | Bladder carcinoma | Prior to 1/1/98 | N | |
| J82 | 69 | 21/9/04 | 4 | 2 | Human | Mycoplasma -ve, Bladder carcinoma | Prior to 1/1/98 | N | |
| JFCF-6/T.1R | 11/5/07 | 5 | 2 | Human | Alt cell line from Roger Reddel/Jeremy Henson | 2/5/07 | B2007/115543 | N | |
| K1E6 | 44 | 20/1/06 | 6 | 3 | Human | Prior to 1/1/98 | N | ||
| K1E6 clone1 | 39 | 22/3/01 | 8 | 2 | Human | weaned | Prior to 1/1/98 | N | |
| K1E7 HPVE6 clone 1 | 32 | 18/11/98 | 6 | 2 | Human | Don't use | Prior to 1/1/98 | N | |
| K1E7 neo | 10 | 12/12/00 | 6 | 2 | Human | Prior to 1/1/98 | Y | ||
| K1E7 neo | 12 | 30/7/01 | 6 | 3 | Human | Prior to 1/1/98 | Y | ||
| K1E7 neo clone 3 | 37 | 18/11/98 | 6 | 2 | Human | Don't use | Prior to 1/1/98 | N | |
| K1E7 scxneo | 10 | 12/12/00 | 6 | 1 | Human | Prior to 1/1/98 | N | ||
| K1E7 scxneo | 49 | 4/8/01 | 6 | 3 | Human | Prior to 1/1/98 | N | ||
| K1E7 scxneo clone 6 | 47 | 18/11/98 | 6 | 2 | Human | Don't use | Prior to 1/1/98 | N | |
| K1EGE7 | 8 | 1 | Human | Prior to 1/1/98 | N | ||||
| K1 neo | 54 | 22/10/04 | 18 | 3 | Human | Prior to 1/1/98 | Y | ||
| K1 neo | 55 | 06 | 15 | 1 | Human | Prior to 1/1/98 | Y | ||
| K1 neo | 27/2/05 | 6 | 2 | Human | Prior to 1/1/98 | Y | |||
| K1 neo clone 3 | 46 | 128/4/05 | 8 | 1 | Human | Prior to 1/1/98 | N | ||
| K1 neo | 300108 | 8 | 11 | Human | Prior to 1/1/98 | N | |||
| K1 scx | 52 | 070301 | 8 | 1 | Human | Weaned | Prior to 1/1/98 | N | |
| K1 scx | 6 | 1 | Human | Prior to 1/1/98 | Y | ||||
| K562 | 2 | 27/10/95 | 10 | 1 | Human | N | |||
| KMST-6 | Human | Alt cell line from Roger Reddel/Jeremy Henson | 2/5/07 | B2007/115543 | N | ||||
| Leiden | 59 +pd11 | 1/4/04 | 18 | 6 | next square 1P 60.5???? | N | |||
| Leyden red cells | 59 | 28/5/02 | 10 | 5 | N | ||||
| LN-18 | 1 | 13/5/04 | 15 | 4 | Human | CRL 2610 | Prior to 1/1/98 | Y | |
| LN-18 | 15 | 8/7/04 | 15 | 3 | Human | CRL 2610 | Prior to 1/1/98 | Y | |
| MB468 | 11 | 2/3/98 | 5 | 5 | Human | Mycoplasma +ve | Prior to 1/1/98 | N | |
| MCF7 | 7 | 160708 | 9 | 4 | Human | Y | |||
| MCF7 | 1 | 9 | 1 | Human | N | ||||
| MCF7 | 130606 | 8 | 3 | Human | N | ||||
| MCF7 | 6 | 140208 | 8 | 1 | Human | N | |||
| MDA-MB-157 | 30/5/03 | 10 | 1 | Human | N | ||||
| MDA-MB-231 | 2 | 2/4/01 | 7 | 4 | Human | Prior to 1/1/98 | N | ||
| MG63 | 97 | 6/11/96 | 10 | 1 | Human | From Roger Reddell | N | ||
| MO59J | ?\'06 | 16 | 3 | N | |||||
| MO59J | 11 | 1 | N | ||||||
| MO59K | 86 | 9/8/05 | 16 | 4 | N | ||||
| MO59K | 07 | 16 | 3 | N | |||||
| MRC-5 | 14 | 6/11/98 | 7 | 2 | Human | Human lung fibroblasts | Prior to 1/1/98 | N | |
| MRC-5 | 37 | 13/8/01 | 9 | 11 | Human | Human lung fibroblasts | Prior to 1/1/98 | N | |
| NCI H209 | 26 | 27/10/95 | 10 | 1 | Human | From Roger Reddell | N | ||
| NFF pcDNA3 | 24/11/03 | 3 | 3 | Human | Normal foreskin fibroblast | 2001012404 | N | ||
| NFF rYB1 | 24/11/03 | 3 | 7 | Human | Normal foreskin fibroblast | 2001012404 | N | ||
| NFF rYB1 B9 | 27/4/01 | 2 | 9 | Human | Normal foreskin fibroblast | 2001012404 | N | ||
| NFF rYB1 B9 | 23/6/06 | 2 | 3 | Human | Normal foreskin fibroblast | 2001012404 | N | ||
| NHA | 2 | 12/9/05 | 8 | 7 | Human | 1.29 E6 cells, Normal Human Astrocyte | N | ||
| NHA | 2 | 12/9/05 | 8 | 1 | Human | Normal Human Astrocyte | N | ||
| NHA | 3 | 7/10/05 | 7 | 1 | Human | Normal Human Astrocyte | N | ||
| NHA | 5 | 7/10/05 | 7 | 1 | Human | Normal Human Astrocyte | N | ||
| NHA | 5 | 7/10/05 | 7 | 5 | Human | Normal Human Astrocyte | N | ||
| NHA | 6 | 7/10/05 | 8 | 1 | Human | Normal Human Astrocyte | N | ||
| NZB1 | 17 | 22/12/04 | 15 | 3 | Human | Glioma study | N | ||
| NZB4 | 13 | 12/6/05 | 15 | 2 | Human | Glioma study | N | ||
| NZB5 | 10 | 18/3/05 | 15 | 3 | Human | Glioma study | N | ||
| NZB5 | 10 | 1/4/05 | 16 | 2 | Human | Glioma study | N | ||
| NZB8 | 12 | 5/1/05 | 15 | 2 | Human | Glioma study | N | ||
| NZB9 | 13 | 5/1/05 | 15 | 2 | Human | Glioma study | N | ||
| NZB11 | 11 | 3/1/05 | 15 | 3 | Human | Glioma study | N | ||
| NZB12 | 19 | 05 | 16 | 2 | Human | Glioma study | N | ||
| PAM | 11 | 1 | N | ||||||
| RIMV | 10/10/96 | 1 | 1 | Human | Prior to 1/1/98 | N | |||
| RIMV | 31/1/01 | 1 | 4 | Human | Prior to 1/1/98 | N | |||
| RIMV RD | 247 | 22/2/01 | 4 | 4 | Human | Prior to 1/1/98 | N | ||
| RKF | 5/11/97 | 3 | 2 | Human | = IIICF/c | N | |||
| RKF/6 | 34 | 23/2/96 | 1 | 1 | Human | = IIICF/c | N | ||
| RKFC | 31 | 14/12/93 | 3 | 1 | Human | = IIICF/c | N | ||
| RKF/C | 33 | 19/2/96 | 2 | 2 | Human | = IIICF/c | N | ||
| RKF/C | 34 | 23/2/96 | 1 | 1 | Human | Mycoplasma -ve, = IIICF/c | N | ||
| RKO | 13 | 5/7/01 | 6 | 1 | Human | Prior to 1/1/98 | N | ||
| RKO | 13+2pd | 13/8/04 | 6 | 1 | Human | Prior to 1/1/98 | N | ||
| RKO | 19 | 1/11/06 | 6 | 3 | Human | Prior to 1/1/98 | N | ||
| RKO | 6 | 1 | Human | Prior to 1/1/98 | N | ||||
| SaOs-2 | 47 | 22/1/02 | 6 | 1 | Human | Bone (osteosarcoma) | Prior to 1/1/98 | Y | |
| SaOs-2 | 47 | 18/3/03 | 6 | 2 | Human | Bone (osteosarcoma) | Prior to 1/1/98 | Y | |
| SaOs-2 | 49 | 20/1/06 | 4 | 4 | Human | Bone (osteosarcoma) | Prior to 1/1/98 | Y | |
| SaOs-2 | 50 | 24/11/03 | 2 | 2 | Human | Bone (osteosarcoma) | Prior to 1/1/98 | Y | |
| SaOs-2 | 50 | 1/5/06 | 6 | 3 | Human | Bone (osteosarcoma) | Prior to 1/1/98 | Y | |
| SaOs-2 | 52 | 24/5/03 | 6 | 1 | Human | Bone (osteosarcoma) | Prior to 1/1/98 | Y | |
| SaOs-2 | 55 | 28/1/04 | 6 | 1 | Human | Bone (osteosarcoma) | Prior to 1/1/98 | Y | |
| SaOs-2 | 55 | 10/6/04 | 6 | 3 | Human | Bone (osteosarcoma) | Prior to 1/1/98 | Y | |
| SaOs-2 | 55 | 16/6/04 | 6 | 1 | Human | Bone (osteosarcoma) | Prior to 1/1/98 | Y | |
| SaOs-2 | 56 | 2/2/04 | 1 | 3 | Human | Bone (osteosarcoma) | Prior to 1/1/98 | Y | |
| SF268 | 05 | 16 | 1 | Human | N | ||||
| SF268 | 06 | 16 | 5 | Human | N | ||||
| SF268 | 17 | 5 | Human | N | |||||
| SF295 | 06 | 16 | 2 | Human | N | ||||
| SF295 | 17 | 2 | Human | N | |||||
| SF539 | 06 | 15 | 2 | Human | N | ||||
| SK-LU-1 | Human | Alt cell line from Roger Reddel/Jeremy Henson | 2/5/07 | B2007/115543 | N | ||||
| SKMEL5 | 20/7/01 | 4 | 1 | Human | Media is RPMI/obtained from Genesis | Y | |||
| SKMEL5 | 30/4/02 | 4 | 1 | Human | Media is RPMI/obtained from Genesis | Y | |||
| SKMEL5 | 29/11/02 | 4 | 2 | Human | Media is RPMI/obtained from Genesis | Y | |||
| SKMEL5 | 26/6/03 | 4 | 2 | Human | Media is RPMI/obtained from Genesis | Y | |||
| SKOV3 | 3 | 16/3/01 | 8 | 2 | Human | N | |||
| SKOV3 | 4 | 14/1/04 | 8 | 1 | Human | N | |||
| SNB75 | 16/3/05 | 16 | 2 | Human | Large Fl | N | |||
| SNB75 | 06 | 16 | 5 | Human | N | ||||
| SNB75 | 17 | 2 | Human | N | |||||
| SW620 | 10 | 18/2/98 | 5 | 2 | Human | Mycoplasma -ve | Prior to 1/1/98 | N | |
| SW620 | 14 | 18/6/001 | 5 | 6 | Human | Prior to 1/1/98 | N | ||
| T24 | 2 | 12/6/02 | 3 | 1 | Human | Bladder Carcinoma | Prior to 1/1/98 | N | |
| T24 | 40 | 27/9/90 | 3 | 1 | Human | Bladder Carcinoma | Prior to 1/1/98 | N | |
| T24 | 43 | 20/6/97 | 3 | 1 | Human | Bladder Carcinoma | Prior to 1/1/98 | N | |
| T24 | 45 | 30/7/01 | 3 | 1 | Human | Bladder Carcinoma | Prior to 1/1/98 | N | |
| T47D | 6 | 4/2/04 | 14 | 4 | Human | N | |||
| T98G | 446 | 19/7/98 | 7 | 1 | Human | Glioblastoma, from Roger Reddell | Prior to 1/1/98 | N | |
| T98G | 449 | 24/11/04 | 7 | 1 | Human | Glioblastoma, from Roger Reddell | Prior to 1/1/98 | N | |
| T98G | 454 | 7/5/04 | 7 | 2 | Human | Glioblastoma, from Roger Reddell | Prior to 1/1/98 | N | |
| T98G | 456 | 05 | 15 | 2 | Human | Glioblastoma, from Roger Reddell | Prior to 1/1/98 | N | |
| Te671 | 14/5/99 | 4 | 1 | Human | ATCC CRL8805 | Prior to 1/1/98 | N | ||
| Te671 | 30/1/01 | 1 | 2 | Human | Prior to 1/1/98 | N | |||
| U2OS | Human | Alt cell line from Roger Reddel/Jeremy Henson | 2/5/07 | B2007/115543 | N | ||||
| U2OS | 32 | 30/10/96 | 2 | 1 | Human | V05 | Prior to 1/1/98 | N | |
| U2OS | 34 | 19/1/01 | 2 | 2 | Human | Prior to 1/1/98 | N | ||
| U2OS | 36 | 18/12/03 | 2 | 2 | Human | Prior to 1/1/98 | N | ||
| U2OS | 43 | 16/12/05 | 2 | 2 | Human | Prior to 1/1/98 | N | ||
| U87 | 35 | 1/11/05 | 8 | 1 | Human | N | |||
| U87MG | 30 | 05 | 15 | 1 | Human | N | |||
| U87MG | 57 | 06 | 15 | 1 | Human | N | |||
| U118MG | 5 | 06 | 16 | 3 | Human | N | |||
| U118MG | 07 | 16 | 4 | Human | N | ||||
| U251 | 06 | 16 | 1 | Human | N | ||||
| U251 | 11 | 1 | Human | N | |||||
| U251MG | 10 | 06 | 15 | 3 | Human | Oscar | N | ||
| W138 VA13/2RA | 11/5/07 | 5 | 2 | Human | Alt cell line from Roger Reddel/Jeremy Henson | 2/5/07 | B2007/115543 | N | |
| W138 VA13/2RA | 280 | 2/8/01 | 4 | 1 | Human | Mycoplasma +ve, From Roger Reddell, SV40 transformed | N | ||
| W138 VA13/2RA | 281 | 13/12/02 | 17 | 10 | Human | Mycoplasma +ve, From Roger Reddell, SV40 transformed | N | ||
| WERI-Rb-1 | 159 | 21/8/01 | 10 | 4 | Human | RPMI | 2001012464 | N | |
| WERI-Rb-1 | 162 | 12/9/01 | 10 | 7 | Human | RPMI, no pen/strep | 2001012464 | N | |
| WMM1175D2 | 4 | 150908 | 15 | 4 | Human | p16-/- line pair with WMM1175p16WTA4. Requires Hygromycin. | '08 | NOC99008 | N |
| WMM1175D2 | 3 | 150908 | 15 | 3 | Human | p16-/- line pair with WMM1175p16WTA4. Requires Hygromycin. | '08 | NOC99008 | N |
| WMM1175p16WTA4 | 4 | 150908 | 15 | 3 | Human | p16WT, pair with WMM1175D2 line. requires hygromycin | '08 | NOC99008 | N |
| WMM1175p16WTA4 | 4 | 030908 | 15 | 3 | Human | p16WT, pair with WMM1175D2 line. requires hygromycin | '08 | NOC99008 | N |
| Y79 | 12 | 10/8/01 | 10 | 4 | Human | RPMI, Retinoblastoma | 23/7/01 | 2001012464 | N |
| Y79 | 14 | 16/8/01 | 10 | 4 | Human | RPMI, Retinoblastoma | 23/7/01 | 2001012464 | N |
| Y79 | 17 | 12/9/01 | 10 | 7 | Human | RPMI, no pen/strep, Retinoblastoma | 23/7/01 | 2001012464 | N |
Rhodri Harfoot 00:49, 25 May 2009 (EDT)
